Nextcure Stock Performance
| NXTC Stock | USD 13.10 0.14 1.06% |
On a scale of 0 to 100, NextCure holds a performance score of 7. The company secures a Beta (Market Risk) of 0.49, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, NextCure's returns are expected to increase less than the market. However, during the bear market, the loss of holding NextCure is expected to be smaller as well. Please check NextCure's semi variance, as well as the relationship between the daily balance of power and price action indicator , to make a quick decision on whether NextCure's current price movements will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in NextCure are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, NextCure exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (1.06) | Five Day Return 18.12 | Year To Date Return (1.36) | Ten Year Return (94.51) | All Time Return (94.51) |
Last Split Factor 1:12 | Last Split Date 2025-07-14 |
1 | NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference | 11/20/2025 |
2 | What sentiment indicators say about NextCure Inc. stock - Stock Surge Risk Adjusted BuySell Alerts - Newser | 12/04/2025 |
3 | Is NextCure Inc. stock a buy on dips - 2025 Earnings Impact Weekly Stock Breakout Alerts - | 12/18/2025 |
4 | Buyout Rumor Can NextCure Inc stock deliver 10 annual returns - Weekly Risk Summary Safe Entry Point Identification - moha.gov.vn | 01/13/2026 |
5 | Acquisition by Cobourn Steven P. of 14670 shares of NextCure at 10.85 subject to Rule 16b-3 | 01/30/2026 |
6 | Can NextCure Inc. stock double in next 5 years - July 2025 Levels AI Powered Market Trend Analysis - mfd.ru | 02/05/2026 |
| Begin Period Cash Flow | 13.1 M | |
| Total Cashflows From Investing Activities | 55.3 M |
NextCure Relative Risk vs. Return Landscape
If you would invest 1,015 in NextCure on November 17, 2025 and sell it today you would earn a total of 295.00 from holding NextCure or generate 29.06% return on investment over 90 days. NextCure is currently generating 0.5867% in daily expected returns and assumes 6.2455% risk (volatility on return distribution) over the 90 days horizon. In different words, 56% of stocks are less volatile than NextCure, and 89% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NextCure Target Price Odds to finish over Current Price
The tendency of NextCure Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 13.10 | 90 days | 13.10 | about 21.54 |
Based on a normal probability distribution, the odds of NextCure to move above the current price in 90 days from now is about 21.54 (This NextCure probability density function shows the probability of NextCure Stock to fall within a particular range of prices over 90 days) .
NextCure Price Density |
| Price |
Predictive Modules for NextCure
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as NextCure. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NextCure's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
NextCure Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. NextCure is not an exception. The market had few large corrections towards the NextCure's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold NextCure, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of NextCure within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.79 | |
β | Beta against Dow Jones | 0.49 | |
σ | Overall volatility | 1.46 | |
Ir | Information ratio | 0.12 |
NextCure Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of NextCure for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for NextCure can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| NextCure is way too risky over 90 days horizon | |
| NextCure appears to be risky and price may revert if volatility continues | |
| NextCure has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (55.65 M) with loss before overhead, payroll, taxes, and interest of (54.2 M). | |
| NextCure currently holds about 185.49 M in cash with (40.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.68. | |
| NextCure has a frail financial position based on the latest SEC disclosures | |
| Roughly 20.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Can NextCure Inc. stock double in next 5 years - July 2025 Levels AI Powered Market Trend Analysis - mfd.ru |
NextCure Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of NextCure Stock often depends not only on the future outlook of the current and potential NextCure's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NextCure's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.3 M | |
| Cash And Short Term Investments | 68.6 M |
NextCure Fundamentals Growth
NextCure Stock prices reflect investors' perceptions of the future prospects and financial health of NextCure, and NextCure fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NextCure Stock performance.
| Return On Equity | -1.17 | ||||
| Return On Asset | -0.58 | ||||
| Current Valuation | 20.98 M | ||||
| Shares Outstanding | 3.51 M | ||||
| Price To Earning | (25.44) X | ||||
| Price To Book | 1.93 X | ||||
| Price To Sales | 9.52 X | ||||
| Gross Profit | (54.2 M) | ||||
| EBITDA | (54.34 M) | ||||
| Net Income | (55.65 M) | ||||
| Cash And Equivalents | 185.49 M | ||||
| Cash Per Share | 6.68 X | ||||
| Total Debt | 5.95 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 33.87 X | ||||
| Book Value Per Share | 8.84 X | ||||
| Cash Flow From Operations | (40.8 M) | ||||
| Earnings Per Share | (23.81) X | ||||
| Market Capitalization | 45.92 M | ||||
| Total Asset | 80.86 M | ||||
| Retained Earnings | (380.14 M) | ||||
| Working Capital | 62.23 M | ||||
| Current Asset | 46.99 M | ||||
| Current Liabilities | 5.53 M | ||||
About NextCure Performance
By analyzing NextCure's fundamental ratios, stakeholders can gain valuable insights into NextCure's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if NextCure has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NextCure has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.79) | (0.83) | |
| Return On Capital Employed | (0.96) | (1.01) | |
| Return On Assets | (0.79) | (0.83) | |
| Return On Equity | (0.98) | (0.93) |
Things to note about NextCure performance evaluation
Checking the ongoing alerts about NextCure for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NextCure help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NextCure is way too risky over 90 days horizon | |
| NextCure appears to be risky and price may revert if volatility continues | |
| NextCure has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (55.65 M) with loss before overhead, payroll, taxes, and interest of (54.2 M). | |
| NextCure currently holds about 185.49 M in cash with (40.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.68. | |
| NextCure has a frail financial position based on the latest SEC disclosures | |
| Roughly 20.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Can NextCure Inc. stock double in next 5 years - July 2025 Levels AI Powered Market Trend Analysis - mfd.ru |
- Analyzing NextCure's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NextCure's stock is overvalued or undervalued compared to its peers.
- Examining NextCure's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NextCure's management team can have a significant impact on its success or failure. Reviewing the track record and experience of NextCure's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NextCure's stock. These opinions can provide insight into NextCure's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for NextCure Stock analysis
When running NextCure's price analysis, check to measure NextCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextCure is operating at the current time. Most of NextCure's value examination focuses on studying past and present price action to predict the probability of NextCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextCure's price. Additionally, you may evaluate how the addition of NextCure to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stocks Directory Find actively traded stocks across global markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |